Detalhe da pesquisa
1.
A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder.
Int J Neuropsychopharmacol
; 24(2): 89-96, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920647
2.
Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
BMC Gastroenterol
; 18(1): 69, 2018 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788903
3.
Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.
J Clin Psychopharmacol
; 41(1): 76-77, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208710
4.
A Review of Clinical Trials Conducted With Oral, Multicomponent Dietary Supplements for Improving Photoaged Skin.
J Drugs Dermatol
; 14(12): 1453-61, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659939
5.
Long-term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life.
Addiction
; 118(5): 890-900, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524904
6.
Struggling With Recovery From Opioids: Who Is at Risk During COVID-19?
J Addict Med
; 17(3): e156-e163, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267169
7.
Recovery from opioid use disorder: A 4-year post-clinical trial outcomes study.
Drug Alcohol Depend
; 234: 109389, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287034
8.
PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.
J Clin Psychiatry
; 82(5)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551218
9.
Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS.
Drug Alcohol Depend
; 229(Pt B): 109057, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794061
10.
Analysis of the symptom response to esomeprazole 20 mg over days 1-4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials.
BMJ Open Gastroenterol
; 6(1): e000278, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297231
11.
Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
Clin Ther
; 39(5): 960-970, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28431766
12.
A multicenter, placebo-controlled, double-blind clinical trial assessing the effects of a multicomponent nutritional supplement for treating photoaged skin in healthy women.
J Cosmet Dermatol
; 16(1): 120-131, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27781390
13.
Corrigendum to "Recovery from opioid use disorder: A 4-year post-clinical trial outcomes study" [Drug Alcohol Depend., 234 (2022), 109389].
Drug Alcohol Depend
; 241: 109687, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334989
14.
Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
Clin Drug Investig
; 36(7): 531-8, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27074935
15.
A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
Postgrad Med
; 128(6): 577-83, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27331882
16.
A placebo-controlled, double-blind clinical trial to evaluate the efficacy of Imedeen(®) Time Perfection(®) for improving the appearance of photodamaged skin.
Clin Cosmet Investig Dermatol
; 9: 63-70, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042135
17.
Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Curr Med Res Opin
; 31(2): 243-50, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25478944